keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nemorubicin (PNU 152243) is a doxorubicin derivative that differs significantly from its parent drug in terms of spectrum of antitumor activity, metabolism and toxicity profile. The drug is active on tumors resistant to alkylating agents, topoisomerase II inhibitors and platinum derivatives.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 51.00 | |
5 mg | In stock | $ 122.00 | |
10 mg | In stock | $ 197.00 | |
25 mg | In stock | $ 455.00 | |
50 mg | In stock | $ 672.00 | |
100 mg | In stock | $ 956.00 |
Description | Nemorubicin (PNU 152243) is a doxorubicin derivative that differs significantly from its parent drug in terms of spectrum of antitumor activity, metabolism and toxicity profile. The drug is active on tumors resistant to alkylating agents, topoisomerase II inhibitors and platinum derivatives. |
Synonyms | Methoxymorpholinyldoxorubicin, PNU-152243A, PNU 152243 |
Molecular Weight | 643.64 |
Formula | C32H37NO13 |
CAS No. | 108852-90-0 |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (69.91 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Nemorubicin 108852-90-0 Others FCE 23762 FCE-23762 Methoxymorpholinyldoxorubicin inhibit Methoxymorpholinyl doxorubicin PNU-152243A PNU152243 PNU 152243 Inhibitor PNU-152243 FCE23762 inhibitor